LA Clavell
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
-
- Acute Lymphoblastic Leukemia research
Papers in
-
- Acute Lymphoblastic Leukemia research 6
-
- Acute Myeloid Leukemia Research 1
- Chronic Myeloid Leukemia Treatments 1
- Hematopoietic Stem Cell Transplantation 1
- Co-authors
- SE Sallan (5 shared papers)JM Pesando (2 shared papers)SF Schlossman (2 shared papers)RD Gelber (3 shared papers)HJ Cohen (3 shared papers)J. Robert Cassady (2 shared papers)Suzanne Hitchcock‐Bryan (1 shared paper)Adlette C. Inati (1 shared paper)
- Journals
- Blood (6 papers)Leukemia (1 paper)PubMed (1 paper)
- Partner nations
- United StatesPuerto RicoCanada
In The Last Decade
LA Clavell
8 papers receiving 508 citations
Peers
Comparison fields: 5 of 65
- Hematology 134
- Public Health, Environmental and Occupational Health 265
- Radiology, Nuclear Medicine and Imaging 207
- Genetics 88
- Pediatrics, Perinatology and Child Health 127
Countries citing papers authored by LA Clavell
This map shows the geographic impact of LA Clavell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by LA Clavell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites LA Clavell more than expected).
Fields of papers citing papers by LA Clavell
This network shows the impact of papers produced by LA Clavell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by LA Clavell. The network helps show where LA Clavell may publish in the future.
Co-authors
The 19 scholars most cited alongside LA Clavell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1981 | 273 | |
| 2 | 2000 | 143 | |
| 3 | 1983 | 87 | |
| 4 | 1991 | 76 | |
| 5 | 1981 | 12 | |
| 6 | Piperacillin and gentamicin as non toxic empirical therapy in pediatric patients with fever and neutropenia. | 1987 | 4 |
| 7 | 1991 | 3 | |
| 8 | 1983 | 1 |
About LA Clavell
LA Clavell is a scholar working on Public Health, Environmental and Occupational Health, Hematology, Pediatrics, Perinatology and Child Health, Pulmonary and Respiratory Medicine and Genetics, having authored 8 papers that have together received 599 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (6 papers), Cancer-related cognitive impairment studies (2 papers), Childhood Cancer Survivors' Quality of Life (2 papers), Acute Myeloid Leukemia Research (1 paper), Glycosylation and Glycoproteins Research (1 paper), Chronic Myeloid Leukemia Treatments (1 paper), Hematopoietic Stem Cell Transplantation (1 paper) and Antibiotics Pharmacokinetics and Efficacy (1 paper). The work is most often cited by research in Hematology (134 citations), Public Health, Environmental and Occupational Health (265 citations), Radiology, Nuclear Medicine and Imaging (207 citations), Genetics (88 citations) and Pediatrics, Perinatology and Child Health (127 citations). LA Clavell has collaborated with scholars based in United States, Puerto Rico and Canada. Frequent co-authors include SE Sallan, JM Pesando, SF Schlossman, RD Gelber, HJ Cohen, J. Robert Cassady, Suzanne Hitchcock‐Bryan, Adlette C. Inati, Yves Samson and Lipton Jm. Their work appears in journals such as Blood, Leukemia and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.